About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,539 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,539 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7161-7180 of 7,539 trials

CompletedAdapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthThis research study will test the efficacy of interactive, web-based interventions that improve diet, physical activity and weight management changes among early stage survivors…NCT04000880·Birmingham, Alabama and 1 other TerminatedOutcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational StudyThe purpose of this research study is to monitor the feasibility and outcome of the Active Surveillance Program for men with low risk prostate cancer.NCT01376661·Orange, California CompletedCognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and SurvivorsBackground: \- People who have cancer have more medical problems if they smoke. Some studies show that smoking even makes cancer treatment less effective.NCT02233842·Bethesda, Maryland

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

UnknownWindow Study of ZD4054 in Metastatic Prostate CancerThis is a prospective study in which patients with castrate-resistant prostate cancer and bone metastases will undergo imaging, donate blood, bone marrow and urine samples, and…NCT01168141·Manchester

TerminatedAn Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate CancerThis Phase 2 Open-label Study examines the efficacy, safety, tolerability, and pharmacokinetics (PK) of tomivosertib (eFT508) in Patients with advanced CRPC.NCT03690141·New Haven, Connecticut and 9 others

WithdrawnPSMA-PET/MRI Low- and Intermediate-Risk Prostate CancerThe goal of this study is to determine the safety of using PSMA-PET/mpMRI to define radiotherapy targets, while meeting all current planning criteria.NCT04243941

CompletedUltrasound for Detection of Prostate CancerClinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.NCT05736094·Oslo

TerminatedCan Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?Because of the high incidence of post-radiation erectile dysfunction (ED), up to 72% after external-beam radiotherapy, this patient category represents a most difficult…NCT00215631·Rotterdam

CompletedA Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate CancerThe purpose of this clinical study is to assess the safety and tolerability of BMS-641988 once daily orally in Japanese patients with castration resistant prostate cancerNCT00644488·Hidaka, Saitama and 2 others

CompletedRadiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate CancerThe purpose of this study is to test the safety and side effects "of "ultra-hypofractionated" radiation therapy when used after brachytherapy (radiation implants).NCT02280356·Basking Ridge, New Jersey and 5 others

CompletedSe-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy ParticipantsThis randomized phase I trial studies the side effects and the best dose of Se-methyl-seleno-L-cysteine or selenomethionine in preventing prostate cancer in healthy participants.NCT01497431·Chicago, Illinois and 2 others

CompletedA Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology SettingThe purpose of this study is to temporally evaluate the impact of abiraterone acetate (ZYTIGA) therapy on Patient Reported Outcomes (PROs) and on clinical outcomes in the…NCT02364531·Calgary, Alberta and 40 others

RecruitingComparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone TherapyThis study is evaluating whether acupuncture may help reduce hot flashes in men receiving hormone therapy for prostate cancer.NCT07594002·Lexington, Kentucky

CompletedImpact on Quality of Life 3 Years After Diagnosis of Prostate CancerTo study the quality of life of patients with prostate cancer at a distance from their care at a time when they are supposed to have taken a "normal" life and compared to subjects…NCT02854982·Nîmes, Gard

RecruitingThe Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADTProstate cancer is characterised by its slow progression nature, and even for metastatic disease, the 5-year survival is up to 30%.NCT06163924·Hong Kong

CompletedPembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair DefectsThis is a multicenter phase 2 open label study of pembrolizumab in patients with metastatic castrate resistant prostate cancer (mCRPC) with or without DNA damage repair defects.NCT03248570·San Francisco, California

TerminatedAcupuncture in Treating Hot Flashes in Patients With Prostate CancerRATIONALE: Acupuncture may help relieve hot flashes in patients with prostate cancer.NCT00244894·Portland, Oregon and 1 other

CompletedSafety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.The present clinical trial is a dose comparison of a multi-component active immunotherapy designed to stimulate an immune reaction to specific tumor associated antigens which are…NCT00423254·Tuscon, Arizona and 4 others

CompletedLapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate CancerThis phase II trial studies how well lapatinib ditosylate works in treating patients with a rising prostate-specific antigen (PSA), a protein made by the prostate gland…NCT00103194·Philadelphia, Pennsylvania

CompletedAtorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerRATIONALE: Atorvastatin calcium and celecoxib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT01220973·Detroit, Michigan and 3 others

PreviousPage 359 of 377Next